MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$1,279K
EPS
$0.07
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development expenses
631
General and administrative expenses
614
Operating loss
-1,245
Total financial expense, net
-34
Net loss and comprehensive loss
-1,279
Basic EPS
0.07
Diluted EPS
0.07
Basic Average Shares
19,551,719
Diluted Average Shares
19,551,719
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss andcomprehensive loss-$1,279K Operating loss-$1,245K Total financialexpense, net-$34K Research and developmentexpenses$631K General andadministrative expenses$614K

Raphael Pharmaceutical Inc. (RAPH)

Raphael Pharmaceutical Inc. (RAPH)